People who have lung cancer have been put on a trial by researchers in Oxford with a new drug as the believed to be beneficial for those who have the disease.

People who are no longer being benefited with chemotherapy are being put under the trial and the treatment is supposed to stop the growth of cancer cells.

At the Oxford Cancer Research Centre, the trial is one of the first to go ahead.

There might be an increase in the survival rate of people who have been diagnosed with lung cancer with the help of the drugs, according to the trial's chief investigator Dr Denis Talbot.

The Cancer Research team at the university conducted the pre-clinical investigations of the drug.

Lung cancer cells were worked on by the drug, according to the investigation.

Dr Talbot said, “Survival from this disease still remains low," he added. "One reason is that the majority, 65-75 per cent, of lung cancer patients are diagnosed when the cancer has already become aggressive, which makes it more difficult to treat successfully.”

People who have given up hope needs to be helped urgently and developing new drugs might bring back the hope among lung cancer patients.